Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIM - Song, K.-A., Niederst, M. J., Lochmann, T. L., Hata, A. N., Kitai, H., Ham, J., Floros, K. V., Hicks, M. A., Hu, H., Mulvey, H. E., Drier, Y., Heisey, D. A. R., Hughes, M. T., Patel, N. U., Lockerman, E. L., Garcia, A., Gillepsie, S., Archibald, H. L., Gomez-Caraballo, M., Nulton, T. J., Windle, B. E., Piotrowska, Z., Sahingur, S. E., Taylor, S. M., Dozmorov, M., Sequist, L. V., Bernstein, B., Ebi, H., Engelman, J. A., Faber, A. C. (The American Association for Cancer Research (AACR), 2018)
6128587
Keywords: WW-YZ